I think the evidence is pretty clear that even starting in the seventies, from seizures done by NIDA and governments that track the rates, there was always high-THC cannabis available at the time. I think we've seen an increase in the rates of THC that came with people producing indoors, as opposed to there being an outdoor supply. But there's certainly no evidence of greater harm associated with those higher rates of THC. People tend to self-titrate; they use the amount of cannabis they need and then they stop using it. I think it's a concern, but I don't think we've seen any evidence of an actual public health harm tied directly to those THC levels.
What I can tell you is that right now at Tilray, interestingly enough, one of our top-selling cannabis strains that's being used by patients is a high-CBD strain. It's low in THC. Patients are looking to try different modes and approaches to cannabis that don't involve intoxication necessarily.
I think through a regulated system, whether it be for medical or recreational use, giving people knowledge about what they're using, letting them know what's in it, the level of THC and CBD, is probably the best harm reduction tool we can hand to Canadian medical or recreational cannabis users, so that they actually know what they're getting. On the black market, unfortunately, there are no controls for that. There are no age controls, no quality controls, and that's a problem.